![Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF) Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)](https://www.frontiersin.org/files/MyHome%20Article%20Library/966968/966968_Thumb_400.jpg)
Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
![Herzuma (trastuzumab biosimilar) for the Treatment of Breast and Gastric Cancers - Clinical Trials Arena Herzuma (trastuzumab biosimilar) for the Treatment of Breast and Gastric Cancers - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-Herzuma.jpg)
Herzuma (trastuzumab biosimilar) for the Treatment of Breast and Gastric Cancers - Clinical Trials Arena
![CardioMEMS | Pulmonary Artery Pressure Monitoring | Heart Failure | Heart & Vascular Services | University Hospitals | Cleveland, OH | University Hospitals CardioMEMS | Pulmonary Artery Pressure Monitoring | Heart Failure | Heart & Vascular Services | University Hospitals | Cleveland, OH | University Hospitals](https://www.uhhospitals.org/-/media/Images/UH-Services/Heart-and-Vascular/CardioMEMS/cardiomems-procedure-video.jpg)
CardioMEMS | Pulmonary Artery Pressure Monitoring | Heart Failure | Heart & Vascular Services | University Hospitals | Cleveland, OH | University Hospitals
![Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy | PNAS Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy | PNAS](https://www.pnas.org/cms/10.1073/pnas.1606444113/asset/e66b2551-10d4-4730-b71c-9a079ed5155d/assets/graphic/pnas.1606444113fig04.jpeg)
Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy | PNAS
![Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF) Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)](https://www.frontiersin.org/files/Articles/966968/fcvm-09-966968-HTML/image_m/fcvm-09-966968-g001.jpg)
Frontiers | Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
![Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy | Communications Biology Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy | Communications Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42003-022-04021-4/MediaObjects/42003_2022_4021_Fig4_HTML.png)
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy | Communications Biology
![CardioMEMS | Pulmonary Artery Pressure Monitoring | Heart Failure | Heart & Vascular Services | University Hospitals | Cleveland, OH | University Hospitals CardioMEMS | Pulmonary Artery Pressure Monitoring | Heart Failure | Heart & Vascular Services | University Hospitals | Cleveland, OH | University Hospitals](https://www.uhhospitals.org/-/media/Images/UH-Services/Heart-and-Vascular/CardioMEMS/Abbott-CardioMEMS-1.jpg)